On Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) opened higher 6.58% from the last session, before settling in for the closing price of $8.06. Price fluctuations for TERN have ranged from $1.87 to $9.03 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 16.38% over the last five years. Company’s average yearly earnings per share was noted -0.67% at the time writing. With a float of $69.63 million, this company’s outstanding shares have now reached $87.47 million.
The firm has a total of 59 workers. Let’s measure their productivity.
Terns Pharmaceuticals Inc (TERN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Terns Pharmaceuticals Inc is 20.43%, while institutional ownership is 82.85%. The most recent insider transaction that took place on Oct 01 ’25, was worth 7,407. In this transaction Chief Medical Officer of this company sold 944 shares at a rate of $7.85, taking the stock ownership to the 51,520 shares. Before that another transaction happened on Jul 01 ’25, when Company’s Chief Medical Officer sold 853 for $4.27, making the entire transaction worth $3,640. This insider now owns 52,464 shares in total.
Terns Pharmaceuticals Inc (TERN) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.28 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.32) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.18% during the next five years compared to 16.38% growth over the previous five years of trading.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Check out the current performance indicators for Terns Pharmaceuticals Inc (TERN). In the past quarter, the stock posted a quick ratio of 24.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.05, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.26 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
Analysing the last 5-days average volume posted by the [Terns Pharmaceuticals Inc, TERN], we can find that recorded value of 2.37 million was better than the volume posted last year of 1.2 million. As of the previous 9 days, the stock’s Stochastic %D was 56.44%.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 92.01%, which indicates a significant increase from 78.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.63 in the past 14 days, which was higher than the 0.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.65, while its 200-day Moving Average is $4.89. Now, the first resistance to watch is $9.05. This is followed by the second major resistance level at $9.51. The third major resistance level sits at $10.14. If the price goes on to break the first support level at $7.95, it is likely to go to the next support level at $7.32. Now, if the price goes above the second support level, the third support stands at $6.86.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
There are currently 87,511K shares outstanding in the company with a market cap of 751.72 million. Presently, the company’s annual sales total 0 K according to its annual income of -88,850 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -24,090 K.
